Phase 3 Alogliptin Pediatric StudyResearch Question:
Does the drug alogliptin help children age 10-17 with type 2 diabetes?
Basic Study Information
Purpose:Location: University of Rochester
This study will evaluate the efficacy and safety of alogliptin 25 mg once daily (QD)
to placebo when administered as monotherapy, or when added onto a background of metformin
alone, insulin alone, or a combination of metformin and insulin in pediatric participants
to 17 years of age with type 2 diabetes mellitus (T2DM).
Study Contact InformationStudy Coordinator: Takeda Study Registration Call Center
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search